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Abstract. Objectives: Envenomation by Loxosceles
species (brown recluse) spiders results in large der-
mal inflammatory lesions. Venom-induced dermal in-
flammation occurs indirectly via soluble mediators of
inflammation. This study aimed to explore whether
the anatomic extent of dermonecrotic arachnidism is
due to the cascade of soluble proinflammatory medi-
ators elicited by venom deposited at the bite site, or
due to diffusion of the venom per se. Methods: Three
New Zealand white rabbits received intradermal L.
reclusa venom (3-mg) injections in the flank. At the
time of maximum dermal inflammation (24 hr),
paired 4-mm dermal biopsies were obtained in 2-cm
intervals extending 0 to 12 cm from the inoculation
site. Normal dermal tissue was obtained from the op-
posite flank to serve as a negative control. One biopsy
sample from each interval was homogenized and as-
sayed for myeloperoxidase (MPO) activity and for the
presence of venom via an enzyme immunoassay
(EIA). The other paired dermal biopsy was sectioned,
and examined for the presence of polymorphonuclear
neutrophils (PMNs) by microscopy. Lesional areas
were measured using digital images imported into
imaging software. Results: Mean 6 SD lesional di-
ameter 24 hours post inoculation measured 9.18 6
0.64 cm. Venom was detected in biopsies 0 to 10 cm
from the injection site. As expected, the highest
venom concentrations were measured at the inocu-
lation site (4.28 6 3.9 ng/4 mm). In addition, PMNs
and MPO were detected up to 8 and 10 cm from the
inoculation site, respectively. Neither PMNs nor MPO
was detected in tissue absent of venom (kappa = 0.88,
p < 0.001). Conclusions: Loxosceles venom diffuses
from the envenomation site. The extent of dermal in-
flammation mirrors the extent of Loxosceles venom
diffusion. This observation implies that the venom it-
self defines the extent and magnitude of tissue injury
following Loxosceles envenomation. Key words: Lox-
osceles; spider; venom; arachnidism. ACADEMIC
EMERGENCY MEDICINE 2001; 8:309–314
LOXOSCELES arachnids are indigenousAmerican spiders that possess a venom ca-
pable of causing intense dermal inflammation and
disfiguring necrotic ulcers.1,2 Among the 54 recog-
nized species of Loxosceles that are found in North
America3, L. reclusa, commonly called the brown
recluse spider, is the major species responsible for
envenomation in the United States.2 Clinical pre-
sentation varies from local cutaneous inflamma-
tion and necrosis to systemic loxoscelism. The bite,
which initially may cause only minor discomfort,
begins as an enlarging circular area of erythema
and edema that extends 5–10 cm or more (in se-
vere cases) in diameter. A centrally located necrotic
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ulcer often forms 8–24 hours following envenom-
ation.1,2
We recently produced fragment antigen-binding
(Fab) fragments that are effective in attenuating
venom-induced dermal inflammation if adminis-
tered intradermally within 4–8 hours following
venom inoculation.4 Since individuals bitten by
Loxosceles species spiders generally seek medical
attention later than this time frame, we set out to
better understand the relative importance of
venom diffusion versus mediator diffusion. This is
an important issue from both conceptual and prac-
tical standpoints since virtually all Loxosceles an-
tivenom investigations have used the intradermal
approach.4–8 The decreased efficacy of intradermal
application of antivenom over time may be due to
a rapid diffusion of venom away from the focal
point of envenomation. Another possibility is that
the events that result in inflammation and necro-
sis may be initiated rapidly following venom inoc-
ulation. In this scenario, soluble mediators of in-
flammation are induced and secreted by dermal
cells shortly after envenomation. Once the early
events leading to inflammation have begun, venom
neutralization with antibody-binding fragments
may occur too late to be effective. This is plausible
since Loxosceles venom does not induce dermone-
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crotic arachnidism via direct effects on dermal tis-
sue.9 The current model summarizing the cellular
and molecular basis for tissue events postulated to
occur following Loxosceles envenomation is as fol-
lows (Fig. 1): after envenomation dermal endothe-
lial and epithelial cells produce and secrete the
chemokines interleukin-8,10–12 growth-related on-
cogene-alpha,11,12 and monocyte chemoattractant
protein-1.11 Endothelial cells secrete the cytokine
granulocyte/ macrophage-colony-stimulating factor
and express the adhesion molecule E-selectin on
the cell surface.10 Neutrophils migrate to the bite
site and adhere to intercellular junctions via the
E-selectin tethering protein.10 Neutrophils are sub-
sequently activated and degranulate, thus result-
ing in tissue inflammation and necrosis.10
In view of the indirect mechanism of Loxosce-
les-induced dermal inflammation, we set out to in-
vestigate the hypothesis that the immediate pres-
ence of venom is not required in the lesional area
in order to induce dermonecrotic arachnidism.
METHODS
Study Design. This was a prospective, random-
ized, controlled, unblinded laboratory investiga-
tion examining whether the immediate presence of
Loxosceles venom is required to induce dermal in-
flammation in the rabbit model. The study had the
approval of the University of Michigan Committee
on the Use and Care of Animals. All experiments
were in accord with the standards outlined in the
Guide for the Care and Use of Laboratory Animals,
and were supervised by veterinarians from the
Unit for Laboratory and Animal Care of the Uni-
versity of Michigan Medical School.
Study Setting and Animal Subjects. Inbred
New Zealand white rabbits (n = 3) were used for
this investigation. The white rabbit is a well-es-
tablished animal model for cutaneous arachnidism
because it displays local and systemic reactions
similar to those of humans.13 Rabbits were ran-
domized by number drawing and received L. re-
clusa venom (3 mg intradermally) in the flank. This
venom dose was chosen since it results in repro-
ducible (and easily measured) lesional areas in the
30–50-cm2 range in pilot animals. Although the ac-
tual amount of venom deposited during a native
spider bite is not known, the amount of venom ob-
tained from a spider during a single electrical
stimulation during commercial milking is approx-
imately 2–3 mg (personal communication, Charles
Kristensen, SpiderPharm, Feasterville, PA).
Study Protocol. Digital photographs of the in-
flammatory lesions were taken 24 hours following
venom inoculation and images were imported into
a computer. We have observed that peak dermo-
necrotic inflammation occurs at the 24-hour time
point in the rabbit model. Lesional areas were
traced and measured using National Institutes of
Health (NIH) imaging software. Animals were sub-
sequently sacrificed and multiple-paired 4-mm
dermal biopsies were obtained in 2-cm intervals 0
to 12 cm from the inoculation site. Normal dermal
tissue was obtained from the opposite flank to
serve as a negative control. One biopsy sample
from each interval was homogenized and assayed
for myeloperoxidase (MPO) content (a sensitive
measure of neutrophil accumulation) and for the
presence of venom via an enzyme immunoassay
(EIA) developed in our laboratory, as described be-
low. The other paired dermal biopsy was sectioned,
stained with hematoxylin and eosin, and examined
for the presence of polymorphonuclear neutrophils
(PMNs) by microscopy. The main outcome measure
was the correlation of the presence of venom with
the presence markers of inflammation (neutro-
phils, and MPO content).
Measurements. An EIA was developed to allow
measurement of tissue content of Loxosceles spe-
cies venom. The EIA method used in this investi-
gation is a modification of the enzyme-linked im-
munosorbent assay (ELISA) procedure described
by Smith (1993).14 Polyclonal IgG antibody to Lox-
osceles venom used for the EIA was raised and pu-
rified using methods previously described.4
Standard 96-well, flat-bottomed microtiter
plates (Corning Glass Works, Corning, NY) were
coated with Loxosceles polyclonal IgG antibody. Af-
ter overnight binding of the capture antibody [4
mg/mL in phosphate-buffered saline (PBS), pH
7.4], plates were incubated with blocking buffer
[PBS pH 7.4, 1% bovine serum albumin (BSA),
0.05% Tween 20 (Zymed Labs, San Francisco, CA)]
for two hours and washed twice (0.05% Tween 20
in PBS). Loxosceles venom standards were added
in triplicate and incubated for two hours. Plates
were washed twice with buffer followed by the ad-
dition of the respective biotinylated rabbit poly-
clonal detection Loxosceles IgG antibody (4 mg/mL
in PBS, pH 7.4). After plates were washed four
times with buffer, streptavidin horseradish perox-
idase 1:4,000 dilution (Neutralite, catalog number
7200-05, Southern Biotechnology Associates, Bir-
mingham, AL) was added for 30 minutes. Plates
were then washed six times with EIA wash buffer,
and finally exposed to 2,29-Azino-di-[3-ethylbenz-
thiazoline sulfonate (6)] diammonium salt crystals
(ABTS, Boehringer-Mannheim Biochemica, Indi-
anapolis, IN, #1 112 422) for 35–40 minutes. Fi-
nally, absorbance was read at 405 nm on a model
ELX808, Bio-Tek (Winooski, VT), microplate reader.
Myeloperoxidase activity, a sensitive measure
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Figure 1. Schematic diagram reviewing the mechanism of Loxosceles venom-induced dermal inflammation. A)
intradermal deposition of venom; B) induction of the neutrophil-tethering molecule E-selectin on endothelial cell
surfaces; C) endothelial and epithelial cell secretion of chemokines interleukin-8 (IL-8), growth-related oncogene-
alpha (GROa), monocyte chemoattractant protein-1 (MCP-1) and granulocyte/macrophage-colony-stimulating fac-
tor (GM-CSF); D) neutrophil migration and tethering to endothelial cell surfaces via E-selectin; and E) activation
and degranulation of neutrophils with resultant tissue injury.10, 11
of neutrophil accumulation, was measured in der-
mal biopsies. At the time of sacrifice (24 hours fol-
lowing venom inoculation), multiple paired 4-mm
dermal biopsies were obtained in 2-cm intervals 0
to 12 cm from the inoculation site. Normal dermal
tissue was obtained from the opposite flank to
serve as a negative control. The specimens were
instantly frozen with liquid nitrogen and stored
prior to analysis. Using a polytron tissue homoge-
nizer (Tissue Tearor, Biospec, Bartlesville, OK),
the skin biopsies were homogenized on ice in 500-
mL PBS pH 7.4 containing 0.1% Tween 20. Sam-
ples were sonicated on ice and insoluble material
was removed by centrifugation at 3,000 rpm for 10
minutes. Five mL of tissue extract (PBS pH 7.4
and 0.1% Tween 20) were incubated with 100 mL
of 2,29-Azino-di-[3-ethylbenzthiozoline sulfonate]
diammonium salt solution (ABTS substrate, Boeh-
ringer Mannhiem) in triplicate and the maximum
velocity of the substrate/MPO chromogenic reac-
tion (Vmax) was measured by monitoring the 96-
well low-protein binding flat-bottom plates (Corn-
ing Glass Works) at 405 nm over a 2-minute period
(Bio-Tek ELX808 microplate reader). Kinetic cal-
culations were performed using KC3 software (Bio-
Tek). The MPO activity in samples was determined
using a standard curve of purified MPO (Calbi-
ochem, San Diego, CA). The MPO values are re-
ported as units of activity/4-mm biopsy.
Data Analysis. The main goal of the analysis
was in assessing the relationship between the
presence of venom and the presence of markers of
inflammation (neutrophils, and MPO content). We
were interested in assessing the level of agreement
between venom, MPO, and white blood cells, and
this was measured using kappa statistics. Kappa
gives a measure of agreement after accounting for
the agreement by chance alone. Kappa has a max-
imum of 1 when agreement is perfect, and a value
of zero indicates no agreement better than by
chance. In addition, interrater kappa statistics
were obtained between the two investigators who
reviewed the same tissue biopsies for the presence
of PMNs. A high interrater kappa would support
high reliability in tissue PMN determination.
RESULTS
Lesional Area Determination. At 24 hours the
lesions had reached a mean 6 SD area of dermal
inflammation and edema of 67.21 6 17.85 cm2 with
a mean 6 SD diameter of 9.18 6 0.64 cm.
Myeloperoxidase Activity and Neutrophil Deter-
mination. Figure 2 summarizes MPO data of the
4-mm biopsies taken at the end of the 24-hour
study period. Elevated dermal MPO content was
detected 0–10 cm from the venom inoculation
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Figure 2. Myeloperoxidase (MPO), polymorphonuclear neutrophil (PMN), Loxosceles venom mean 6 SD concen-
trations in serial dermal biopsies 0–12 cm from the inoculation site 24 hours postenvenomation. The level of
agreement for the presence of the three parameters as assessed by kappa = 0.88, p < 0.001.
site. The highest concentration was found in der-
mal tissue obtained 2 cm from the venom inocu-
lation site with a mean 6 SD MPO level of
76.1 6 22.7 u/4-mm biopsy. Myeloperoxidase
was not detected in dermal tissue obtained 12 cm
from the inoculation site nor in the negative con-
trol. Figure 2 summarizes the neutrophil concen-
trations detected in the lesions. Polymorpho-
nuclear neutrophils were detected 0–8 cm from the
inoculation site; the maximum number of PMNs
was found at the inoculation site with a mean 6
SD of 41 6 4.9 PMNs/5.5 3 10-2 mm2. No PMNs
were seen under microscopy at 10 and 12 cm from
the injection site, nor in the negative normal skin
control. Interrater kappa agreement between the
two investigators who reviewed tissue biopsies for
the presence (or absence) of PMNs was 1.0 (p <
0.01).
Venom Content in Dermal Tissue. We had pre-
viously raised and purified anti-Loxosceles poly-
clonal IgG antibodies and developed a sensitive en-
zyme immunoassay to detect Loxosceles species
venom. Figure 2 summarizes the venom concentra-
tions found in dermal biopsies with our venom im-
munoassay. The highest venom concentrations
were found at the inoculation site with a mean 6
SD of 4.28 6 3.9 ng/4-mm biopsy. Loxosceles re-
clusa venom was detected in each biopsy 0–10 cm
from the inoculation site. No venom was detected
at 12 cm nor in the negative control taken from
the opposite flank.
Summary. Figure 2 summarizes the level of
agreement between the three parameters we mea-
sured. The lesion extended just over 9.18 6 0.64
cm in diameter. This clinical observation was re-
flected in our inability to detect MPO, PMNs, and
migrated venom past the 10-cm dermal biopsies.
Kappa gives a measure of agreement of our param-
eters after accounting for agreement by chance
alone. The kappa value between venom and MPO
was 0.91 (p < 0.001), that between venom and
PMNs was 0.90 (p < 0.001), and that between all
three was 0.88 (p < 0.001), thus demonstrating sig-
nificant correlation between the parameters mea-
sured.
DISCUSSION
Using the rabbit model of dermonecrotic arach-
nidism, we found a significant correlation between
the presence of dermal inflammation as deter-
mined by elevated concentrations of inflammatory
cells and MPO content, and the immediate pres-
ence of L. reclusa venom in serial dermal biopsies.
Tissue biopsies without detectable Loxosceles
venom did not possess dermonecrotic arachnidism
either by clinical exam or as determined by the
lack of measurable parameters used to quantify
tissue inflammation. Loxosceles venom contains
the enzyme hyaluronidase, which, like some bac-
teria, may promote such a spread of venom
through tissue.15 Following envenomation, the
venom may rapidly diffuse throughout dermal tis-
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sue, inducing tissue inflammation and necrosis in
a circular ‘‘wave’’ initiated from the focal point of
venom deposition.
Given the known indirect nature of the mech-
anism of dermonecrotic arachnidism, we consid-
ered distant tissue signaling from the point of en-
venomation a plausible hypothesis for the rapid
development of tissue inflammation. Loxosceles
venom produces dermal inflammation and necrosis
via induction and release of soluble mediators of
inflammation.10–12 This investigation demonstrates
that although the physiological events leading to
tissue inflammation and necrosis are indirect, the
dermopathological effects of Loxosceles envenom-
ation nonetheless require the immediate presence
of venom.
We previously found evidence of venom migra-
tion in a single rabbit that was inoculated intra-
dermally with an overwhelmingly large quantity
(20 mg) of L. deserta venom.16 The animal devel-
oped a large necrotic lesion at the site of inocula-
tion, with small areas of necrosis appearing to
‘‘drip’’ down the side of the animal in a gravitation-
ally dependent manner.16 Using a modified tissue
EIA, L. deserta venom was detected throughout
the 15-cm necrotic inflammatory dermal lesion af-
ter 24 hours.16 This finding was limited by the
physiologically irrelevant amount of venom inocu-
lated in the animal model. Although the actual
amount of venom deposited during a native spider
bite is not known, the amount of venom obtained
from a spider during a single electrical stimulation
during commercial milking is approximately 2–3
mg (personal communication, Charles Kristensen,
SpiderPharm, Feasterville, PA).
CLINICAL RELEVANCE
In this controlled investigation, using a relevant
quantity of L. reclusa venom, we detected venom
throughout dermal tissue, which had clinical signs
of inflammation. The spread of venom away from
the site of inoculation has direct clinical relevance.
We previously found that intradermally adminis-
tered anti-Loxosceles Fab fragments were shown
to inhibit the formation of venom-induced dermal
inflammation when administered early following
venom inoculation in the rabbit model.4 However,
there was decreasing efficacy of the lesion attenu-
ating effect when treatment time was delayed.
Other investigators have studied intradermal ad-
ministration of intact polyclonal anti-Loxosceles
antibodies with varying degrees of success, but all
have observed similar decreases in efficacy when
delay follows venom inoculation.5,7,8
A rapid migration of venom away from the point
of inoculation would make an intradermal admin-
istration of antivenom at the bite site a relatively
inefficient means of accessing, binding, and neu-
tralizing venom.
LIMITATIONS AND FUTURE QUESTIONS
A limitation in this study pertains to its unblinded
design in MPO, PMN, and venom quantification.
Unblinded parameter determination cannot con-
trol for investigator bias. We have demonstrated
that the immediate presence of Loxosceles venom
is required for the development of dermonecrotic
arachnidism. However, several questions are
raised by this investigation. Since Loxosceles
venom diffuses throughout the dermis rapidly fol-
lowing venom inoculation, the intradermal ‘‘point’’
application of antivenom would not appear to be
an effective means of applying antivenom. This
manner of antivenom application would likely not
allow antibodies effective access for venom binding
and neutralization. Future studies would logically
focus on whether parenteral administration or
other more diffuse dispersal of anti-Loxosceles Fab
antivenom might provide better access for venom
neutralization. In addition, given the time-depen-
dent factor of tissue spread of venom, is it possible
to rapidly identify individuals who may benefit
clinically from antivenom therapy prior to the de-
velopment of fully expressed clinically character-
istic dermal necrosis 24–48 hours later?
CONCLUSIONS
In this investigation using the New Zealand rabbit
model, Loxosceles venom diffused throughout der-
mal tissue over a 24-hour period. Loxosceles-in-
duced dermal inflammation strongly correlated
with the immediate presence of venom. Although
the mechanism of Loxosceles-induced inflamma-
tion is an indirect one, the immediate tissue pres-
ence of venom is nonetheless required for dermo-
necrotic arachnidism.
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